| Individual Articles - Sep/Oct 2001 - Bioidentical Hormone Replacement Therapy |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Reed-Kane Dana
|
Sep/Oct 2001
Pg. 332-335
View Sample |
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
|
Sep/Oct 2001
Pg. 336-338
|
Bioidentical Hormones in the Treatment of Osteoporosis
Boomsma Diane
|
Sep/Oct 2001
Pg. 339-341
|
The Value of Hormone Assessment
Collins Joseph J
|
Sep/Oct 2001
Pg. 342-344
|
Estrogen Replacement: A Review of Current Literature
Parazewski Kevin
|
Sep/Oct 2001
Pg. 346-350
|
Treating Andropause: Prohormones and Hormone Metabolic Modifiers
Biundo Bruce
|
Sep/Oct 2001
Pg. 351-353
|
Bioidentical Topical Progesterone: A Survey of Patients
Warren Aileen, Listecki Robert E
|
Sep/Oct 2001
Pg. 354-355
|
Book Reviews: Hormone Replacement Therapy
Paoletti James E
|
Sep/Oct 2001
Pg. 356-357
|
Charting Systems: Organizing Information Effectively
Anneken Michael W, Flick Celeste C
|
Sep/Oct 2001
Pg. 360-361
|
Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
|
Sep/Oct 2001
Pg. 362-364
|
Compounding in History: Treatment at the Change of Life
Worthen Dennis B
|
Sep/Oct 2001
Pg. 365-367
|
Flush Powder, No. 2
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Tincture of Black Cohosh
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Lydia Pinkham's Vegetable Compound
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
The Basics of Compounding: Tablets and Pills
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 369-371
|
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 374
|
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 375
|
Libido Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 376
|
Progesterone 50-mg/mL Clear Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 377
|
Progesterone Low-Potency 0.0065% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 378
|
Sildenafil 1% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 379
|
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 380
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 381
|
Testosterone 25-mg/mL Clear Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 382
|
Testosterone 2% Scalp Lotion
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 383
|
Compounding Containment Devices: Buyer Be Aware
Kastango Eric S
|
Sep/Oct 2001
Pg. 384-388
|
Capsule and Tablet Disintegrating Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 389-390
|
Calculations
Prince Shelly J
|
Sep/Oct 2001
Pg. 391
|
Developing a Capsule Formulation
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 392-393
|
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Sep/Oct 2001
Pg. 394-396
|
Assessment of the Stability of Teicoplanin in Intravenous Infusions
Galanti Laurence M, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques
|
Sep/Oct 2001
Pg. 397-400
|
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H, Szwejkowski Jessica, Houston Alana
|
Sep/Oct 2001
Pg. 401-405
|
PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 408
|
